Table 1 Baseline characteristics of study patients before CVVHD initiation
Parameters
|
n=12
|
Baseline data
|
|
Age (median, IQR)
|
57 (47.8, 75)
|
Male (n)
|
8
|
Source of sepsis (n)
- Lung
- Abdomen
- Musculoskeletal system
|
5
5
2
|
Comorbidities (n)
- Diabetes
- Hypertension
- Chronic heart disease
- Chronic lung disease
- Cerebrovascular disease
|
3
6
3
1
3
|
Weight (kg)
|
72.5 (70, 87)
|
Height (cm)
|
176 (165, 179)
|
Parameters on day of enrolment
|
|
Mechanical ventilation (n, %)
|
9 (75%)
|
Vasopressor use (n, %)
|
9 (75%)
|
APACHE II (median, IQR)
|
27 (23, 30)
|
SOFA score (median, IQR)
|
11 (10, 12)
|
Urine output (mL/day)
|
63 (33, 161)
|
Laboratory data (median, IQR)
- Haemoglobin (g/L)
- Urea (mmol/L)
- Creatinine (µmol/L)
- C-reactive protein (mg/L)
|
86 (71, 104)
13.1 (11.5, 18)
287 (150, 438)
127 (82, 228)
|
Abbreviation: IQR = interquartile range; APACHE = Acute Physiologic and Chronic Health Evaluation II, SOFA = Sequential Organ Failure Assessment
Table 2 Pre-filter cytokine concentrations at pre-determined time points
Cytokines
(pg/ml)
|
T0 (n=12)
|
T1 (n=12)
|
T6 (n=12)
|
T24 (n=11)
|
T48 (n=7)
|
p value*
|
IL-2
|
2.68
(0,4.18)
|
1.21
(0, 2.73)
|
0
(0, 2.67)
|
0
(0, 3.32)
|
0
(0, 4.75)
|
<0.001
|
IL-4
|
1.30
(1.17, 1.92)
|
1.4
(1.16, 2.03)
|
1.36
(1.15, 1.84)
|
1.19
(0.99, 2.24)
|
1.19
(0.99,1.94)
|
<0.001
|
IL-6
|
311.03
(30.92, 1175.13)
|
84.22
(35.02, 1336.48)
|
80.64
(30.12, 1273.17)
|
27.48
(23.33, 548.69)
|
90.82
(14.4,153.54)
|
<0.001
|
IL-8
|
83.21
(55.10, 588.14)
|
74.15
(21.79, 446.88)
|
88.83
(20.82, 356.09)
|
60.44
(22.65, 222.59)
|
37.28
(19.99, 77.22)
|
<0.001
|
IL-10
|
9.35
(4.38, 25.46)
|
10.04
(4.35, 27.55)
|
9.03
(3.96, 19.89)
|
6.58
(3.32, 9.42)
|
4.95
(1.54, 6.93)
|
0.008
|
VEGF
|
41.25
(21.78, 64.97)
|
35.86
(10.46, 59.43)
|
29.00
(14.9, 35.68)
|
30.28
(20.77, 39.77)
|
28.64
(13.93, 38.23)
|
<0.001
|
IFN-ƴ
|
1.59
(1.31, 1.92)
|
1.62
(0,2.76)
|
1.01
(0, 2.34)
|
0
(0, 1.89)
|
0
(0, 1.46)
|
<0.001
|
TNF-α
|
5.84
(4.55, 18.03)
|
5.30
(3.2, 13.33)
|
4.63
(3.44, 13.83)
|
4.14
(2.85, 9.1)
|
4.08
(3.14, 4.61)
|
<0.001
|
IL-1α
|
0.72
(0, 1.59)
|
0.24
(0, 1.27)
|
0
(0, 1.07)
|
0
(0, 1.29)
|
0.56
(0, 1.33)
|
<0.001
|
IL-1β
|
1.37
(0.5, 2.79)
|
1.09
(0, 1.71)
|
1.19
(0, 1.77)
|
0
(0, 1.47)
|
0
(0, 1.64)
|
<0.001
|
MCP-1
|
571.9
(335.2, 1436.69)
|
516.75
(311.89, 779.07)
|
457.74
(275.88, 646.24)
|
316.63
(201.93, 742.44)
|
262.63
(116.93, 451.12)
|
<0.001
|
EGF
|
1.34
(0, 1.49)
|
0
(0, 1.66)
|
1.30
(0, 1.62)
|
1.38
(0, 1.68)
|
1.76
(0,1.84)
|
<0.001
|
Abbreviations: IL, interleukin; VEGF, vascular endothelial growth factor; IFN, interferon; TNF, tumor necrosis factor; MCP, monocyte chemoattractant protein; EGF, epidermal growth factor
* P value for differences in cytokine concentrations for all time points using generalized estimating equations (GEE)
Notes: Values expressed as median (interquartile range)
Normal range from literature for baseline cytokine concentrations in sepsis (in pg/mL):
IL-2 = 0 (0-108.5); IL-4 = 8.88 (93.2-202.7); IL-6 = 376 – 2375; TNF-α = 4.43 to 33; IL-8 = 215 to 1349; IL-1β = 0 to 66.02; IL-10 = 88.55 to 638; IFN-ƴ = 20.82 to 275 pg/mL; MCP-1 = 454.2 (97.4-22,000); EGF = 35.9 ± 58.03, VEGF = 27.58 to 1082, IL-1α = 0.12 to 0.36 pg/mL [25-34]
Table 3 Serial cytokine clearance rates by adsorption and diffusion at 1, 6, 24, and 48 hours after continuous veno-venous hemodialysis initiation and time-weighted mean clearance rates
Cytokines
|
|
T1
|
T6
|
T24
|
T48
|
Time-weighted mean
|
IL-2
|
Adsorption
(n=6)
|
3.0
(-21.9, 72)
|
18.5
(11.5, 20.6)
|
18.8
(-3.6, 75)
|
6.4
(-4.0, 9.8)
|
9.8
(-3.8, 46.3)
|
Effluent
(n=6)
|
0
(0, 24.2)
|
0
(0, 0)
|
0
(0, 0)
|
0
(0, 0)
|
0
(0, 0)
|
IL-4
|
Adsorption
(n=12)
|
-54.2
(-107.7, -38.7)
|
-61.0
(-75.3, -44.2)
|
-78.1
(-91.7, -46.9)
|
-61.3
(-67.8, -50.8)
|
-64.0
(-91.2, -43.4)
|
Effluent
(n=12)
|
55.2
(38.9, 69.0)
|
55.9
(50, 66.0)
|
59.3
(52.1, 72.2)
|
68.9
(43.2, 83.9)
|
55.4
(51.3, 69.9)
|
IL-6
|
Adsorption (n=12)
|
-15.3
(-21.6, -3.1)
|
-4.9
(-11.5, 4.8)
|
-13.3
(-20.8, -1.3)
|
-10.6
(-13.1, -5.7)
|
-11.5
(-18.1, 0.9)
|
Effluent
(n=12)
|
10.2
(6.1, 17.3)
|
9.0
(8.1, 10.6)
|
5.6
(2.4, 20.5)
|
2.2
(0, 6.8)
|
7.8
(4.1, 15.7)
|
IL-8
|
Adsorption
(n=12)
|
-44.5
(-66, -23)
|
-42.3
(-224.1, -19)
|
-50
(-243.3, -28.8)
|
-61.8
(-100.9, -2.9)
|
-48.9
(-144.7, -19.0)
|
Effluent
(n=12)
|
37.7
(26.4, 47.8)
|
49.0
(40.8, 87.5)
|
62.7
(24.2, 116.3)
|
32.7
(16.2, 103.1)
|
63.8
(34.7, 93.6)
|
IL-10
|
Adsorption
(n=12)
|
-5.9
(-16.7, 1.6)
|
3.5
(-10.0, 7.1)
|
-6.6
(-10.1, 8.2)
|
-17.2
(-25.7, -8.5)
|
-7.1
(-10.7, 16.9)
|
Effluent
(n=12)
|
0.5
(0, 10.0)
|
0
(0, 1.8)
|
0
(0, 1.8)
|
9.6
(4.5, 21.3)
|
2.2
(0.3, 5.5)
|
VEGF
|
Adsorption
(n=9)
|
-2.7
(-22.8, 11.2)
|
-2.6
(-6.9, 10.6)
|
4.0
(-7.4, 17.2)
|
37.7
(0.5, 100)
|
4.0
(-7.4, 16.9)
|
Effluent
(n=10)
|
5.0
(0, 17.6)
|
0
(0, 20.2)
|
0
(0, 0)
|
0
(0, 16.8)
|
3.4
(0, 19.2)
|
IFN-ƴ
|
Adsorption
(n=7)
|
0
(-20.0, 24.1)
|
7.9
(4.4, 12.3)
|
16.6
(-20.4, 5.7)
|
-16.1
(-20.9, -4.5)
|
-2.3
(-20.3, 11.2)
|
Effluent
(n=7)
|
0
(0, 0)
|
0
(0, 0)
|
0
(0, 0)
|
0
(0, 0)
|
0
(0, 0)
|
TNF-α
|
Adsorption
(n=12)
|
-5.3
(-10.6, 3.5)
|
-7.0
(-12.3, 4.1)
|
-22.8
(-38.8, -13.4)
|
-19.3
(-23.4, -0.6)
|
-10.6
(-23.3, 4.1)
|
Effluent
(n=12)
|
11.6
(0, 17.0)
|
19.0
(13.9, 30.7)
|
26.5
(13.5, 33.2)
|
22.7
(18.5, 28.8)
|
19.0
(9.0, 28.4)
|
IL-1α
|
Adsorption
(n=6)
|
-7.2
(-13.1, 69)
|
-5.6
(-30.2, 5.0)
|
-26.1
(-38.9, -7.7)
|
-11.4
(-46.1, 48.1)
|
-10.2
(-23.2, 4.1)
|
Effluent
(n=6)
|
0
(0, 0)
|
0
(0, 35.0)
|
0
(0, 15.2)
|
0
(0, 9.3)
|
0
(0, 8.6)
|
IL-1β
|
Adsorption
(n=7)
|
-12.2
(-62.3, 0)
|
22.5
(-3.6, 56)
|
-21.1
(-46.0, -10.2)
|
-9.2*
|
-8.6 (-21.1, 3.1)
|
Effluent
(n=7)
|
0
(0, 29.0)
|
0
(0, 20.0)
|
30.0
(0, 61.4)
|
0*
|
0
(0, 31.8)
|
MCP-1
|
Adsorption
(n=12)
|
-31.8
(-19.9, -13.4)
|
-23.1
(-25.4, -17.8)
|
-30.5
(-35.7, -10.9)
|
-22.9
(-40.5, -4.8)
|
-24.9
(-35.7, -10.9)
|
Effluent
(n=12)
|
33.5
(29.7, 46.6)
|
38.2
(35.0, 43.0)
|
31.3
(18.0, 50)
|
32.9
(24.5, 46.6)
|
33.9
(21.6, 43.6)
|
EGF
|
Adsorption
(n=5)
|
0.9
(0.7, 1.7)
|
8.2
(0, 15.1)
|
-7.3
(-14.8, -4.8)
|
-0.2
(-43.0, 3.7)
|
0
(-12, 3.4)
|
Effluent
(n=7)
|
0
(0, 0)
|
0
(0, 0)
|
0
(0, 0)
|
0
(0, 0)
|
0
(0, 0)
|
Abbreviations: IL, interleukin; VEGF, vascular endothelial growth factor; IFN, interferon; TNF, tumor necrosis factor; MCP, monocyte chemoattractant protein; EGF, epidermal growth factor; T1 = 1 hour, T6 = 6 hours, T24 = 24 hours, and T48 = 48 hours
*only one observation
Notes: Values expressed as median (interquartile range)